G1 THERAPEUTICS INC (GTHX)
US3621LQ1099 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -47.97M | -147.56M | -148.35M | -99.25M | -122.45M | |||
| Depreciation Amortization | 513.00K | 530.00K | 470.00K | 580.00K | 360.00K | |||
| Change In Working Capital | -5.20M | -5.31M | -8.84M | -4.08M | 6.07M | |||
| Interest Paid | 8.81M | 7.92M | 2.91M | 1.00M | N/A | |||
| Other non cash items | 14.32M | 23.72M | 24.61M | 19.01M | 16.45M | |||
| OPERATING CASH FLOW | -38.34M | -128.62M | -132.11M | -83.74M | -99.57M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 0.00 | -510.00K | 0.00 | N/A | -2.72M | |||
| Other Investing Activity | 2.81M | -50.02M | 0.00 | 150.00K | N/A | |||
| INVESTING CASH FLOW | 2.81M | -50.53M | 0.00 | 150.00K | -2.72M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -26.69M | 0.00 | 55.00M | 20.00M | N/A | |||
| Stock Issued/Repurchased | 57.00K | 52.54M | 92.27M | 2.31M | 2.71M | |||
| Other Financing Activity | -281.00K | -40.00K | -1.41M | -620.00K | 0.00 | |||
| FINANCING CASH FLOW | -26.91M | 52.50M | 145.86M | 21.69M | 2.71M | |||
| CHANGE IN CASH | -62.44M | -126.65M | 13.75M | -61.90M | -99.58M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -38.34M | -128.62M | -132.11M | -83.74M | -99.57M | |||
| Capital Expenditure | 0.00 | -510.00K | 0.00 | N/A | -2.72M | |||
| FREE CASH FLOW | -38.34M | -129.13M | -132.11M | -83.74M | -102.29M | |||
All data in USD